Guest View
User: Pass: | become a member
Author Archive for Insider Scoop

Earnings Scheduled For October 24, 2014

Courtesy of Benzinga.

Related BMY
Must Watch Stocks for Today
Drug ETFs Attractive Buys On Pullback
Apple Leads the Charge as Earnings Season Heats Up (Fox Business)
Related F
Must Watch Stocks for Today
These 5 Cars Have The Lowest Fuel Economy
Amid Higher Pricing, GM Profit Nearly Doubles (Fox Business)

Bristol-Myers Squibb Company (NYSE: BMY) is projected to report its Q3 earnings at $0.42 per share on revenue of $3.80 billion.

Ford Motor Co (NYSE: F) is estimated to report its Q3 earnings at $0.19 per share on revenue of $33.11 billion.

The Procter & Gamble Company (NYSE: PG) is projected to report its Q1 earnings at $1.07 per share on revenue of $20.83 billion.

Aaron’s (NYSE: AAN) is expected to report its Q3 earnings at $0.37 per share on revenue of $694.64 million.

United Parcel Service (NYSE: UPS) is projected to report its Q3 earnings at $1.29 per share on revenue of $14.20 billion.

Colgate-Palmolive Co (NYSE: CL) is estimated to report its Q3 earnings at $0.76 per share on revenue of $4.44 billion.

Cabot Oil & Gas (NYSE: COG) is projected to report its Q3 earnings at $0.22 per share on revenue of $515.76 million.

Wyndham Worldwide (NYSE: WYN) is estimated to report its Q3 earnings at $1.63 per share on revenue of $1.53 billion.

The Nasdaq OMX Group (NASDAQ: NDAQ) is expected to report its Q3 earnings at $0.70 per share on revenue of $510.60 million.

Avery Dennison (NYSE: AVY) is estimated to report its Q3 earnings at $0.74 per share on revenue of $1.57 billion.

Delphi Automotive PLC (NYSE: DLPH) is projected to report its Q3 earnings at $1.13 per share on revenue of $4.20…
continue reading





Must Watch Stocks for Today

Courtesy of Benzinga.

Related F
These 5 Cars Have The Lowest Fuel Economy
These 5 Cars Have The Highest Fuel Economy
Amid Higher Pricing, GM Profit Nearly Doubles (Fox Business)

Related AMZN
Markets Boosted From Strong Earnings Releases, Jobless Benefits
Amazon Misses On Earnings And Revenue, Shares Tank
Strong 3Q Earnings Boost Investor Confidence (Fox Business)

Some of the stocks that may grab investor focus today are:

Wall Street expects Ford Motor Co (NYSE: F) to report its Q3 earnings at $0.19 per share on revenue of $33.11 billion. Ford shares rose 0.83% to $14.52 in after-hours trading.

Amazon.com (NASDAQ: AMZN) reported weaker-than-expected third-quarter results and issued a weak sales forecast for the holiday quarter. Amazon.com shares dipped 10.66% to $279.80 in the after-hours trading session.

Analysts are expecting Procter & Gamble Company (NYSE: PG) to have earned $1.07 per share on revenue of $20.83 billion in the first quarter. Procter & Gamble shares rose 0.23% to $83.42 in after-hours trading.

The Nasdaq OMX Group (NASDAQ: NDAQ) is projected to report its Q3 earnings at $0.70 per share on revenue of $510.60 million. Nasdaq OMX shares rose 0.90% to $41.30 in the after-hours trading session.

Microsoft (NASDAQ: MSFT) reported stronger-than-expected fiscal first-quarter results. Microsoft shares gained 3.11% to $46.42 in the after-hours trading session.

Analysts expect Bristol-Myers Squibb Company (NYSE: BMY) to report its Q3 earnings at $0.42 per share on revenue of $3.80 billion. Bristol-Myers Squibb shares climbed 0.19% to $52.60 in after-hours trading.

Colgate-Palmolive Co (NYSE: CL) is expected to report its Q3 earnings at $0.76 per share on revenue of $4.44 billion. Colgate-Palmolive shares declined 0.23% to $64.90 in the after-hours trading session.

Wall Street expects United Parcel Service (NYSE: UPS) to report its Q3 earnings at $1.29 per share on revenue of $14.20 billion. UPS shares surged 1.49% to $101.98 in after-hours trading.

Posted-In: Stocks To WatchEarnings News Guidance Pre-Market Outlook Markets Trading Ideas





UPDATE: Morgan Stanley Reiterates On ResMed Following 1Q15 Earnings Report

Courtesy of Benzinga.

Related RMD
Morning Market Movers
Qualcomm Announces New Connected Health Collaborations at Connect 2014

In a report published Friday, Morgan Stanley analyst Sean Laaman reiterated an Equal-Weight rating on ResMed (NYSE: RMD), and raised the price target from $46.19 to $49.57.

In the report, Morgan Stanley noted, “Currency headwinds and part quarter release of the S10 downplayed expectations ahead of the result. Despite this, RMD beat on US revenue driven by a rapid ramp in generator sales of ~8% with gross margins in-line. We upgrade our forecasts as S10 upside and accessory flow are yet to fully emanate.”

ResMed closed on Thursday at $49.57.

Latest Ratings for RMD

Date Firm Action From To
Oct 2014 Morgan Stanley Maintains Equal-weight
Aug 2014 Jefferies Maintains Hold
Jul 2014 Deutsche Bank Downgrades Buy Hold

View More Analyst Ratings for RMD
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Sean LaamanAnalyst Color Price Target Analyst Ratings





Benzinga's Top Initiations

Courtesy of Benzinga.

Related BABA
BMO Capital Initiates Alibaba Group Holding At Outperform
NY Post Reports Alibaba's Ma Seeking 37% Stake in Lionsgate
Amazon Earnings: What to Expect (Fox Business)

Related MRO
UPDATE: Mizuho Securities Initiates Coverage On Marathon Oil
Mizuho Securities Initiates Marathon Oil With Buy
Energy Stocks Move Higher as Oil Spikes (Fox Business)

Analysts at BMO Capital initiated coverage on Alibaba Group Holding (NYSE: BABA) with a Outperform rating. The target price for Alibaba Group Holding is set to $110. Alibaba Group Holding’s shares closed at $94.45 yesterday.

Analysts at Mizuho Securities initiated coverage on Marathon Oil (NYSE: MRO) with a Buy rating. The target price for Marathon Oil is set to $40. Marathon Oil’s shares closed at $34.73 yesterday.

Barclays initiated coverage on shares of Mattress Firm Holding (NASDAQ: MFRM) with a Overweight rating. The target price for Mattress Firm Holding is set to $70. Mattress Firm Holding’s shares closed at $62.27 yesterday.

Analysts at JMP Securities initiated coverage on shares of Dynex Capital (NYSE: DX) with a Market Outperform rating. The target price for Dynex Capital is set to $9. Dynex Capital’s shares closed at $8.29 yesterday.

Latest Ratings for BABA

Date Firm Action From To
Oct 2014 BMO Capital Initiates Coverage on Outperform
Oct 2014 Barclays Initiates Coverage on Overweight
Oct 2014 Brean Capital Initiates Coverage on Buy

View More Analyst Ratings for BABA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings





Deutsche Bank Raises Price Target On Diamond Offshore

Courtesy of Benzinga.

Related DO
Bank Of America On Offshore Drillers: Too Early For Contrarian Bull Call
Transocean at 52-Week Low on Weak Offshore Drilling Market
Energy Stocks Move Higher as Oil Spikes (Fox Business)

On Friday, analysts at Deutsche Bank maintained the Sell rating on shares of Diamond Offshore Drilling Inc (NYSE: DO) and raised the price target from $22 to $31.

Diamond Offshore announced third quarter 2013 financial results on Thursday, reporting EPS of $0.58, missing estimates by 26 percent.

Following the results, Deutsche Bank analysts feel "there is not enough to get us excited."

Mike Urban stated, "Cash flow is set to decline as midwater rigs roll-off contracts into a market that has little demand for them and the newbuild program is not nearly large enough to offset the lost earnings."

Moreover, Urban declares that "DO’s strong balance sheet puts the company in an attractive position to build/ acquire assets but with negative structural free cash flow that liquidity is increasingly likely to be used for (ultimately unsustainable) dividends."

Shares of Diamond Offshore Drilling Inc recently traded at $39.70, up 0.25 percent.

Latest Ratings for DO

Date Firm Action From To
Oct 2014 Nordea Upgrades Strong Sell Sell
Oct 2014 Deutsche Bank Maintains Sell
Oct 2014 FBR Capital Maintains Market Perform

View More Analyst Ratings for DO
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Mike UrbanAnalyst Color Price Target Analyst Ratings





Brent Set To Post First Weekly Gain In Over A Month

Courtesy of Benzinga.

Related BNO
Brent Lower On Rising Inventories
Brent Prices May Be On The Rebound

Brent crude oil looked set to post its first weekly gain in over a month after reports that Saudi Arabian output was depressed boosted prices.

However, the commodity was under some pressure and traded at $86.33 when Ebola fears resurfaced in the US after another healthcare worker tested positive. 

Doctor Craig Spencer was diagnosed with Ebola on Thursday after working with infected patients in West Africa through the Doctors Without Borders organization.

Spencer’s diagnosis reignited worries about the spread of the disease, especially as Spencer was living in heavily populated New York City. Though the 33 year old doctor had been bowling, on the subway and in a taxi, health officials say the risk of spread was minimal as he was not showing any symptoms until Thursday morning when he was taken from his home into quarantine. 

Meanwhile, investors have been keeping a close eye on OPEC members ahead of the group’s November 27 meeting and looking for any clues about whether or not they will cut down on supply in order to raise prices.

Related Link: New International IPO And Eurozone ETFs

For the moment, the cartel looks unlikely to cut back as several members have expressed their desire to regain market share by accepting the current price levels for an extended period.

Brent saw a boost after Reuters reported that OPEC member Saudi Arabia’s crude output fell significantly from August to September.

The nation supplied only 9.36 million barrels per day to the market in September, 328,000 barrels per day less than it contributed in August. The news helped counterbalance worries about a growing supply glut and buoyed Brent prices.

Posted-In: Craig Spencer OPECNews Commodities Forex Global Pre-Market Outlook Markets Best of Benzinga





Deutsche Bank Adjusts Estimates For Foot Locker For Delayed Lebron Launch

Courtesy of Benzinga.

Related FL
Fast Money Halftime Report Final Trade From October 3: Generac Holdings Inc., Bank of America Corp
Jon Najarian's Foot Locker, Inc. Trade
Finish Line 1Q Profit Doubles to Top Views (Fox Business)

In a report published Friday, Deutsche Bank analyst Paul Trussell reiterated a Buy rating and $59.00 price target on Foot Locker, Inc. (NYSE: FL).

In the report, Deutsche Bank noted, “Earlier this month, NKE (Weiner, Buy) stated that due to a ‘small cosmetic issue’ the release of the Lebron 12 sneaker will be delayed indefinitely. Our channel contacts suggest that the release may be rescheduled for December, although no official date has been announced. We believe the surprising delay (some shipments had already reached stores for its U.S. 10/11/14 debut) is having a modestly negative impact to sales at FL this month. We have tweaked our estimates for SSS and EPS to reflect lost sales and a minor impact from FX. We remain confident of robust sneaker sales near-term, beginning with a plethora of high-priced releases this weekend.”

Foot Locker, Inc. closed on Thursday at $55.14.

Latest Ratings for FL

Date Firm Action From To
Sep 2014 Bank of America Downgrades Buy Neutral
Sep 2014 JP Morgan Maintains Overweight
Sep 2014 Jefferies Initiates Coverage on Buy

View More Analyst Ratings for FL
View the Latest Analyst Ratings

Posted-In: Deutsche Bank Paul TrussellAnalyst Color Reiteration Analyst Ratings





UPDATE: Brean Capital Reiterates On ARRIS Group On 3Q14 Preview

Courtesy of Benzinga.

Related ARRS
Top 4 Mid-Cap Stocks In The Communication Equipment Industry With The Highest EPS
UPDATE: Brean Capital Reiterates On ARRIS Group On Continued Favorable Outlook

In a report published Friday, Brean Capital analyst Todd Mitchell reiterated a Buy rating on ARRIS Group (NASDAQ: ARRS), but lowered the price target from $40.00 to $36.00.

In the report, Brean Capital noted, “We believe Arris is well positioned in key product categories where growth will outstrip overall capital expenditures, and we note that the company has a significantly lower market share outside of the U.S., two factors that we believe point to a multi-year path of sustainable growth. However, Arris is its own worst enemy. Management will only provide one quarter forward guidance, and the market has not acclimated itself to the fact that, post-Motorola, the company is far more diversified than it used to be. Therefore, the stock tends to trade like a semiconductor company when in fact Arris’ business should be far more stable. This is evident in the recent sell-off following cautionary comments from management about 4Q14 during its 2Q14 earnings call. We think the source of these comments could have mitigated and that when Arris gives its official 4Q14 guidance buy-side investors could be pleasantly surprised. However, sell-side estimates for 4Q14 remain stubbornly high, we suspect well above buy-side expectations, creating a conundrum that inhibits multiple expansion. As a result, we are lowering our target price to $36 from $40, but we reiterate our Buy rating.”

ARRIS Group closed on Thursday at $26.87.

Latest Ratings for ARRS

Date Firm Action From To
Oct 2014 Brean Capital Reiterates Buy
Oct 2014 Goldman Sachs Initiates Coverage on Neutral
Aug 2014 Barclays Maintains Equal-weight

View More Analyst Ratings for ARRS
View the Latest Analyst Ratings

Posted-In: Brean Capital Todd MitchellAnalyst Color Price Target Analyst Ratings





Benzinga's Volume Movers

Courtesy of Benzinga.

Related DRIV
Stocks Hitting 52-Week Highs
Morning Market Movers

Related QLIK
Qlik Partners with Fujitsu To Integrate Big Data Solution
Morgan Stanley Revises Its Outlook On Big Data Stocks
Making Money With Charles Payne: 09/29/14 (Fox Business)

Digital River (NASDAQ: DRIV) shares moved up 47.07% to $25.56. The volume of Digital River shares traded was 6637% higher than normal. Digital River agreed to be acquired by an investor group led by Siris Capital Group for $26.00 per share in cash.

Qlik Technologies (NASDAQ: QLIK) shares rose 6.70% to $26.27. The volume of Qlik Technologies shares traded was 687% higher than normal. Qlik Technologies reported Q3 earnings of $0.01 per share on revenue of $131.30 million.

BJ’s Restaurants (NASDAQ: BJRI) shares climbed 20.45% to $39.99. The volume of BJ’s Restaurants shares traded was 592% higher than normal. BJ’s Restaurants reported stronger-than-expected Q3 earnings.

KLA-Tencor (NASDAQ: KLAC) surged 8% to $76.68. The volume of KLA-Tencor shares traded 575% higher than normal. KLA-Tencor reported better-than-expected Q1 results. The company announced a $16.50 per share special dividend and added 3.6 million shares to buyback.

Posted-In: volume moversNews Intraday Update Markets Movers





UPDATE: Morgan Stanley Reiterates On Northern Trust Corporation On Pullback In Expectations

Courtesy of Benzinga.

Related NTRS
Earnings Scheduled For October 15, 2014
Benzinga's Top Upgrades
Week Ahead: Loads of Bank Earnings (Fox Business)

In a report published Friday, Morgan Stanley analyst Betsy L. Graseck reiterated an Underweight rating on Northern Trust Corporation (NASDAQ: NTRS), but lowered the price target from $74.00 to $70.00.

In the report, Morgan Stanley noted, “Although we see 11% upside to current share price, we are Underweight NTRS as we expect other LC banks will outperform on improving credit or accelerating share gain. Drivers to get more positive on the stock are accelerating AUC/AUM wins, faster path to target efficiencies, higher short-end rates. NTRS should be of interest to yield investors as its dividend yield is 2.1% and total yield including stock buybacks is 5.2%.”

Northern Trust Corporation closed on Thursday at $62.86.

Latest Ratings for NTRS

Date Firm Action From To
Oct 2014 Keefe Bruyette & Woods Maintains Market Perform
Oct 2014 Jefferies Maintains Hold
Oct 2014 Deutsche Bank Maintains Hold

View More Analyst Ratings for NTRS
View the Latest Analyst Ratings

Posted-In: Betsy L. Graseck Morgan StanleyAnalyst Color Price Target Analyst Ratings





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!

 
 

Zero Hedge

Why America Ranks 26th In The Developed World For Math (In 1 Common Core Question)

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Among the 34 OECD countries, the US performed below average in mathematics and is ranked 27th, according to The Program For International Student Assessment (PISA).

 

While the U.S. spends more per student than most countries, this does not translate into better performance (e.g. the Slovak Republic, which spends around $53k per student, performs at the same level as the US, which spends over $115k per student).

PISA adds that students in...



more from Tyler

Phil's Favorites

Home Prices Drop in 69 of 70 Chinese Cities; Did the Pool of Greater Fools Run Out?

Courtesy of Mish.

China eased purchase restrictions last month ending its four-year campaign to contain home prices. And what a ridiculous campaign it was. Prices are down less than 1% this month and less then 1% year-over-year.

Bloomberg reports China Home-Price Drop Spreads as Easing Doesn’t Halt Fall.

Prices dropped in 69 of the 70 cities in September from August, the National Bureau of Statistics said in a statement today, the most since January 2011 when the government changed the way it compiles the data. They fell in 68 cities in August.

The central bank on Sept. 30 eased mortgage rules for homebuyers that have paid off existing loans, reversing course after a four-year camp...



more from Ilene

Chart School

World Markets Weekend Update: Selloff Ends, Rally Begins

Courtesy of Doug Short.

In last weekend's update, only one the eight indexes on my watchlist posted a weekly gain. This weekend's numbers have reversed. Seven indexes closed the week with a gain and there were some substantial ones at that. Japan's Nikkei erased the previous week's -5.02% plunge with a 5.22% surge. The S&P 500 finished second with a 4.12% advance. China's Shanghai Composite was the sole loser, down 1.66%.

In fact, the Shanghai Composite remains the only index on the watch list in bear territory -- the traditional designation for a 20% decline from an interim high. The index is down 33.68% from its August 2009 peak. See the table inset (lower right) in the chart below.

Here is a look at 2014 so far....



more from Chart School

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Insider Scoop

UPDATE: Morgan Stanley Reiterates On ResMed Following 1Q15 Earnings Report

Courtesy of Benzinga.

Related RMD Morning Market Movers Qualcomm Announces New Connected Health Collaborations at Connect 2014

In a report published Friday, Morgan Stanley analyst Sean Laaman reiterated an Equal-Weight rating on ResMed (NYSE: RMD), and raised the price target from $46.19 to $49.57.

In the report, Morgan Stanley noted, “Currency headwinds and part quarter release of the S10 downplayed expectations ahead of the result. Despite this, RMD beat on US revenue driv...



http://www.insidercow.com/ more from Insider

Market Shadows

Bill Ackman's Big Pharma Trade Is Making Wall Street A Super Awkward Place

 

#452525522 / gettyimages.com

Intro by Ilene

If you're following Valeant's proposed takeover (or merger) of Allergan and the lawsuit by Allergan against Valeant and notorious hedge fund manager William Ackman, for insider trading this is a must-read article. 

Linette Lopez describes the roles played by key Wall Street hedge fund owners--Jim Chanos, John Paulson, and Mason Morfit, a major shareholder in Valeant. Linette goes through the con...



more from Paul

Option Review

LUV Options Active Ahead Of Earnings

There is lots of action in Southwest Airlines Co. November expiry call options today ahead of the air carrier’s third-quarter earnings report prior to the opening bell on Thursday. Among the large block trades initiated throughout the trading session, there appears to be at least one options market participant establishing a call spread in far out of the money options. It looks like the trader purchased a 4,000-lot Nov 37/39 call spread at a net premium of $0.40 apiece. The trade makes money if shares in Southwest rally 9.0% over the current price of $34.32 to exceed the effective breakeven point at $37.40, with maximum potential profits of $1.60 per contract available in the event that shares jump more than 13% to $39.00 by expiration. In September, the stock tou...



more from Caitlin

Sabrient

Sector Detector: Sharp selloff in stocks sets up long-awaiting buying opportunity

Courtesy of Sabrient Systems and Gradient Analytics

Last week brought even more stock market weakness and volatility as the selloff became self-perpetuating, with nobody mid-day on Wednesday wanting to be the last guy left holding equities. Hedge funds and other weak holders exacerbated the situation. But the extreme volatility and panic selling finally led some bulls (along with many corporate insiders) to summon a little backbone and buy into weakness, and the market finished the week on a high note, with continued momentum likely into the first part of this week.

Despite concerns about global economic growth and a persistent lack of inflation, especially given all the global quantitative easing, fundamentals for U.S. stocks still look good, and I believe this overdue correction ultimately will shape up to be a great buying opportunity -- i.e., th...



more from Sabrient

Digital Currencies

Goodbye War On Drugs, Hello Libertarian Utopia. Dominic Frisby's Bitcoin: The Future of Money?

Courtesy of John Rubino.

Now that bitcoin has subsided from speculative bubble to functioning currency (see the price chart below), it’s safe for non-speculators to explore the whole “cryptocurrency” thing. So…is bitcoin or one of its growing list of competitors a useful addition to the average person’s array of bank accounts and credit cards — or is it a replacement for most of those things? And how does one make this transition?

With his usual excellent timing, London-based financial writer/actor/stand-up comic Dominic Frisby has just released Bitcoin: The Future of Money? in which he explains all this in terms most readers will have no tr...



more from Bitcoin

OpTrader

Swing trading portfolio - week of October 20th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's this week's Stock World Weekly. Just sign in with your PSW user name and password. (Or take a free trial.)

#457319216 / gettyimages.com

 

...

more from SWW

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>